Medical Health Screening Market Report 2026

The medical health screening market size has grown strongly in recent years. It will grow from $19.74 billion in 2025 to $21.06 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, expansion of diagnostic laboratory networks, rising prevalence of chronic diseases, improved access to routine testing services, growth of employer-sponsored health programs.

The medical health screening market size is expected to see strong growth in the next few years. It will grow to $26.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing adoption of personalized medicine approaches, rising integration of digital health platforms, expansion of population-level screening initiatives, growing demand for home-based testing services, increasing focus on early cancer detection. Major trends in the forecast period include increasing adoption of preventive health screening programs, rising use of multi-parameter diagnostic panels, growing demand for early disease detection services, expansion of corporate and occupational health screening, enhanced focus on personalized screening protocols.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical health screening market in the coming years. Chronic diseases are long-term health conditions, such as diabetes, heart disease, and asthma, that typically persist for a year or longer and require ongoing medical care or can limit daily functioning. The rise in chronic diseases is largely attributed to sedentary lifestyles, as prolonged inactivity weakens overall health and increases susceptibility to long-term medical conditions. Medical health screening is crucial for managing chronic diseases, as it enables the early identification of risk factors and symptoms, allowing timely intervention and management that can prevent complications, improve quality of life, and reduce the overall burden of these conditions. For example, in April 2025, according to the International Diabetes Federation, a Belgium-based non-profit organization, 589 million adults aged 20-79 are currently living with diabetes worldwide, and this number is projected to increase to 853 million by 2050. Therefore, the rising prevalence of chronic diseases is fueling the growth of the medical health screening market.

Key companies operating in the medical health screening market are focusing on launching innovative solutions, such as artificial intelligence-powered radiology informatics and cancer screening, to improve early detection, enhance diagnostic accuracy, and streamline clinical workflows. AI-powered radiology informatics and cancer screening utilize artificial intelligence technologies to analyze medical imaging data and identify potential signs of cancer or other abnormalities with greater speed and precision. For instance, in February 2025, DeepHealth, a US-based health informatics company, introduced a new suite of AI-powered radiology informatics and cancer screening solutions built on their cloud-native operating system, DeepHealth OS. This includes the Diagnostic Suite, a unified AI-driven diagnostic workspace, and advanced AI tools for lung, prostate, and brain health screening. These innovations aim to enhance clinical accuracy, optimize workflows, and improve operational efficiency across various healthcare settings.

In January 2023, PAM Group, a UK-based provider of occupational health, rehabilitation, and absence management services, acquired MedProtect for an undisclosed amount. Through this acquisition, PAM Group aims to strategically strengthen its position in the occupational health and wellbeing sector by incorporating MedProtect’s specialized mobile health screening services, enabling the combined organization to offer more cost-effective health solutions to a wider range of clients while supporting continued growth and innovation in the industry. MedProtect is a UK-based company that provides occupational health screening services, offering mobile health screening units for services such as hearing tests, biological monitoring, and lung function assessments.

Major companies operating in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc, Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc, DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc, Freenome Holdings Inc, Genova Diagnostics Inc, Cerba Healthcare SAS, DELFI Diagnostics Inc, Truvian Sciences Inc, ACM Medical Laboratory Inc, LabPlus, Sonic Healthcare Limited.

North America was the largest region in the medical health screening market in 2025. The regions covered in the medical health screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the medical health screening market by increasing costs of imported diagnostic instruments, imaging systems, laboratory reagents, and screening consumables used across routine, cancer, and specialty testing. Hospitals, diagnostic laboratories, and workplace screening programs in North America and Europe are most affected due to dependence on imported medical devices, while Asia-Pacific faces cost pressure on equipment sourcing. These tariffs are raising operational expenses and delaying technology upgrades. However, they are also encouraging domestic manufacturing of diagnostic equipment, local reagent production, and regional supply chain diversification for screening services.

The medical health screening market research report is one of a series of new reports that provides medical health screening market statistics, including medical health screening industry global market size, regional shares, competitors with a medical health screening market share, detailed medical health screening market segments, market trends and opportunities, and any further data you may need to thrive in the medical health screening industry. This medical health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical health screening refers to the systematic process of conducting various tests and examinations on apparently healthy individuals to identify potential health problems or risk factors before symptoms appear. This early detection approach allows healthcare providers to implement timely interventions, reduce disease severity, and improve overall health outcomes through preventive measures.

The primary types of tests in medical health screening include routine tests, non-routine tests, cancer screening tests, specialty tests, and others. Routine tests are standard medical examinations performed regularly to monitor general health and detect potential issues early. Sample types include blood, urine, saliva, and others, and these tests are used by end users such as hospitals and clinics, diagnostic laboratories, workplaces, research institutes, and others.

The medical health screening market includes revenues earned by entities by providing services such as blood pressure measurement, mental health assessment, infectious disease screening, immunization status review, and lifestyle risk assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.